Enhabit (NYSE:EHAB) Trading Down 7%

Shares of Enhabit, Inc. (NYSE:EHAB - Get Free Report) traded down 7% during trading on Tuesday . The stock traded as low as $10.47 and last traded at $10.50. 153,079 shares were traded during mid-day trading, a decline of 76% from the average session volume of 629,042 shares. The stock had previously closed at $11.29.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. UBS Group upgraded shares of Enhabit from a "sell" rating to a "neutral" rating and set a $9.50 price target on the stock in a research report on Thursday, March 7th. TD Cowen assumed coverage on shares of Enhabit in a research report on Tuesday, December 12th. They issued a "market perform" rating and a $12.00 price target on the stock. Jefferies Financial Group lowered their price target on shares of Enhabit from $15.00 to $14.00 and set a "buy" rating on the stock in a research report on Wednesday, March 6th. Finally, Oppenheimer reiterated a "market perform" rating on shares of Enhabit in a research report on Thursday, March 7th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $12.08.

Enhabit Stock Performance

The stock's 50-day moving average is $10.02 and its 200-day moving average is $9.94. The stock has a market cap of $533.20 million, a price-to-earnings ratio of -6.56, a price-to-earnings-growth ratio of 1.78 and a beta of 1.96. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.53 and a quick ratio of 1.53.

Enhabit (NYSE:EHAB - Get Free Report) last announced its earnings results on Wednesday, March 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.02 by $0.01. The firm had revenue of $260.60 million for the quarter, compared to analyst estimates of $260.30 million. Enhabit had a negative net margin of 7.69% and a positive return on equity of 1.55%. During the same quarter last year, the business earned $0.32 earnings per share. Analysts anticipate that Enhabit, Inc. will post 0.24 EPS for the current fiscal year.

Hedge Funds Weigh In On Enhabit

A number of large investors have recently bought and sold shares of EHAB. Northern Trust Corp purchased a new position in Enhabit during the second quarter worth approximately $494,000. Millennium Management LLC purchased a new position in Enhabit during the second quarter worth approximately $230,000. UBS Group AG raised its stake in Enhabit by 407,300.0% during the third quarter. UBS Group AG now owns 12,222 shares of the company's stock worth $171,000 after purchasing an additional 12,219 shares during the period. Dimensional Fund Advisors LP purchased a new position in shares of Enhabit in the 3rd quarter valued at $9,662,000. Finally, Credit Suisse AG purchased a new position in shares of Enhabit in the 3rd quarter valued at $686,000.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.